UTERINE LEIOMYOSARCOMA
Clinical trials for UTERINE LEIOMYOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new UTERINE LEIOMYOSARCOMA trials appear
Sign up with your email to follow new studies for UTERINE LEIOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a pill that blocks estrogen help fight rare uterine cancers?
Disease control Recruiting nowThis phase 2 trial is testing elacestrant, a pill that breaks down estrogen receptors, in 30 people with advanced uterine sarcomas that are fueled by estrogen. The goal is to see if the drug can shrink tumors or slow their growth. Participants must have tumors that strongly expre…
Matched conditions: UTERINE LEIOMYOSARCOMA
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can a common breast cancer drug slow uterine sarcoma?
Disease control Recruiting nowThis phase 2 trial tests whether the drug letrozole can extend the time before uterine leiomyosarcoma returns after initial treatment. About 40 women with early-stage disease will be randomly assigned to take letrozole daily or to be observed without treatment. The main goal is t…
Matched conditions: UTERINE LEIOMYOSARCOMA
Phase: PHASE2 • Sponsor: GOG Foundation • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
AI takes on mysterious uterine tumors: a new hope for accurate diagnosis
Knowledge-focused Recruiting nowThis study is testing whether artificial intelligence can help doctors better classify and predict the behavior of rare smooth muscle tumors of the uterus, including those that are hard to diagnose (called STUMP). Researchers will train AI models on digital images of tumor tissue…
Matched conditions: UTERINE LEIOMYOSARCOMA
Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC